Mexican private equity firm LIV Capital and Singaporean sovereign wealth fund Temasek have acquired a 32% stake in diagnostics healthcare company Grupo Diagnóstico Proa, owner of Laboratorios Chopo. The transaction is subject to the approval of Mexico’s Federal Economic Competition Commission (COFECE).
(El Financiero) Grupo Diagnóstico Proa , owner of Laboratorios Chopo , sold 32 percent of the company’s capital to LIV Capital and Temasek .
Without giving the value of the operation, Proa said in a statement issued Wednesday that the resources will be used to expand operations and the company’s presence in Mexico.
The final closure of the transaction is subject to approval by the Federal Economic Competition Commission (Cofece).
Proa was founded more than 70 years ago by Carlos Pérez Moreno, currently the company operates 275 branches in Mexico under the well-known brand ‘Chopo’.
They offer more than 4,000 tests / services classified between clinical analysis and cabinet tests. Additionally, Proa is the owner and operator of Carpermor , the largest reference laboratory in the country, responsible for the processing of third party tests.
“The favorable demographic trends and the fundamental attractions of the health sector in Mexico present a great opportunity for us,” said José Carlos Pérez, president of the Proa Board of Directors.
